Scotland Continues to Forge Ahead in Stem Cell Research Scotland’s standing as Europe’s largest and most highly regarded stem cell research community has been reaffirmed recently by announcements of funding from the UK Medical Research Council and the British Heart Foundation to the MRC Centre for Regenerative Medicine based at the Edinburgh BioQuarter. As part of a major $25 million boost for UK regenerative medicine, the Edinburgh center will play a key role in the development of new therapies. [PR Newswire Association LLC] Press Release Immune Design Partners with Leading Cancer Organizations to Advance Novel Immunotherapy Research The Cancer Research Institute, the Ludwig Institute for Cancer Research and Immune Design announced that they have signed a collaboration agreement to advance cancer immunotherapy research. Specifically, the partnership will focus on clinical trials to test novel combinations of immunotherapies, including two investigational drugs from Immune Design’s pipeline. [Ludwig Institute For Cancer Research Ltd] Press Release Phase I Trial Uses Enhanced T Cells to Treat Neuroblastoma A phase I clinical trial at Baylor College of Medicine and Texas Children’s Cancer Center using an immunotherapy approach to treating neuroblastoma has received support from the nonprofit organization Solving Kids’ Cancer. The organization provided $153,000 for the trial, which will start this summer. [Baylor College of Medicine] Press Release Argos Therapeutics Announces US and Global Expansion for Ongoing Pivotal Phase III ADAPT Study for Personalized Immunotherapy Argos Therapeutics Inc. announced it has expanded its ADAPT Phase III clinical study for AGS-003 to additional top cancer centers in the United States, Canada and will soon be expanding into Europe and Israel. [Argos Therapeutics Inc.] Press Release Stemline Therapeutics’ SL-401 Receives Orphan Drug Designation for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Stemline Therapeutics, Inc. announced that SL-401 has received Orphan Drug designation from the U.S. Food and Drug Administration for the treatment of BPDCN, a rare and aggressive hematologic malignancy for which there is no effective treatment. [Stemline Therapeutics, Inc.] Press Release IntelliCell BioSciences Receives US Patent for Its Stem Cell Extraction Technology IntelliCell BioSciences, Inc. announced that it has been notified by the US Patent office that its patent for stem cell extraction technology has been published. IntelliCell’s proprietary patented method for deriving blood vessel originated vascular cells from adipose tissue by use of ultrasonic cavitation has been made official. [PR Newswire Association LLC] Press Release LifeSouth Reaches a Milestone with FDA License A journey that began in Gainesville, Florida more than 15 years ago, that’s allowed newborn babies to become lifesavers, reached a milestone, when the Food and Drug Administration (FDA) notified LifeSouth that its license was approved for cord blood manufacturing. [LifeSouth Community Blood Centers] Press Release Federal and State Governments Lend Support to Cord Blood Banking As researchers continue to discover groundbreaking medical therapies using stem cells from umbilical cord blood, Federal and State governments in the United States are ramping up their efforts to support the cord blood industry and educate parents-to-be about banking their babies’ stem cells. The most recent development happened when the New York State Senate introduced a bill to create a public umbilical cord blood banking program within the New York State Department of Health to promote public awareness of the potential benefits of public cord blood banking. [PR Newswire Association LLC] Press Release Global Expert in Lung Disease Joins Cedars-Sinai to Lead New Stem Cell Research Program Barry R. Stripp, PhD, a recognized expert in lung disease and stem cell research, has been named director of the new Lung Stem Cell Research Program that spans the Women’s Guild Lung Institute and the Regenerative Medicine Institute at Cedars-Sinai. [Cedars-Sinai] Press Release First Science Star for Wales Announced A world-leading neurobiologist who will take up a post at the University as the first appointment under the Welsh Government’s £50 million flagship science initiative has been welcomed to Wales and Cardiff by First Minister for Wales and the Minister for Economy & Science. [Cardiff University] Press Release From our sponsor: Free Nature Reviews Immunology poster – Immune Response to HIV. Request a copy. |